Table 1.
Baseline demographic, alcohol use, and smoking variables
| Placebo (n = 15) |
1 mg/day varenicline (n = 20) |
2 mg/day varenicline (n = 20) |
|
|---|---|---|---|
|
|
|||
| Age (years) | 35.27 (9.25) | 33.35 (8.51) | 34.15 (11.59) |
| Sex (% male) | 67% | 60% | 75% |
| Race | |||
| White | 9 (60%) | 10 (50%) | 15 (75%) |
| Other | 6 (40 %) | 10 (50%) | 5 (25%) |
| Marital status | |||
| Not married | 12 (80%) | 16 (80%) | 19 (95%) |
| Married | 3 (20%) | 4 (20%) | 1 (5%) |
| Alcohol use | |||
| AUDIT | 13.67 (7.00) | 13.45 (5.01) | 10.75 (3.92) |
| Drinks/week | 36.24 (29.21) | 32.89 (13.62) | 29.32 (17.57) |
| Drinking episodes/week | 5.33 (1.69) | 4.73 (1.59) | 4.75 (1.61) |
| Smoking Status | |||
| Smokers | 10 (67%) | 13 (65%) | 12 (60%) |
| Nonsmokers | 5 (33%) | 7 (35%) | 8 (40%) |
| Smoking* | |||
| FTND | 5.00 (2.58) | 5.23 (2.09) | 4.67 (2.10) |
| Cig/Day | 14.76 (6.62) | 12.56 (4.98) | 15.95 (6.26) |
Note. AUDIT is the alcohol use disorder identification test. Drinks/week and drinking/episodes week report values from the timeline follow-back. FTND is the Fagerstrom Test of Nicotine Dependence.
*
Variables reported for only smokers (n =35). No ANOVA or chi-square test found any significant difference between groups.